GAO: CDC should reevaluate BioSense redesign

11/23/2008 | Modern Healthcare (free registration)

A new report from the GAO says that the CDC should rethink its redesign of BioSense, an electronic surveillance system that identifies disease patterns. "The costs and benefits of using data from the current implementation of the BioSense system and other similar systems are difficult to measure and compare, and public health and hospital officials with whom we spoke do not document or track the costs and benefits of using these systems," the report said.

View Full Article in:

Modern Healthcare (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI